Anacor Pharmaceuticals, Inc. (ANAC) Posts Q1 Loss of 42c/Share

May 9, 2013 4:46 PM EDT
Get Alerts ANAC Hot Sheet
Trade ANAC Now!
Join SI Premium – FREE
Anacor Pharmaceuticals, Inc. (NASDAQ: ANAC) reported Q1 EPS of ($0.42), $0.03 worse than the analyst estimate of ($0.39). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $2.57 million.

For earnings history and earnings-related data on Anacor Pharmaceuticals, Inc. (ANAC) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment